Perioperative host-tumor inflammatory interactions: A potential trigger for disease recurrence following a curative resection for colorectal cancer

Surgery Today

Volumn 38, Issue 7, 2008, Pages 579-584

  Miki, Chikao ^a   Tanaka, Kouji ^a   Inoue, Yasuhiro ^a   Araki, Toshimitsu ^a   Ohi, Masaki ^a   Mohri, Yasuhiko ^a   Uchida, Keiichi ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colon Cancer; Inflammation; Recurrence

Indexed keywords

CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; SCATTER FACTOR; VASCULOTROPIN;

AUTOCRINE EFFECT; BLOOD TRANSFUSION; CANCER RECURRENCE; COLORECTAL CANCER; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; PERIOPERATIVE PERIOD; REVIEW; SURGICAL STRESS; SURVIVAL TIME; TISSUE REGENERATION; TUMOR GROWTH;

ADENOCARCINOMA; COLECTOMY; COLORECTAL NEOPLASMS; CYTOKINES; HEPATOCYTE GROWTH FACTOR; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; STRESS, PHYSIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 47149118138     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-007-3674-6     Document Type: Review

References (71)

1. Mitry E, Douillard JY, van Cutsem E, Cunningham D, Magherini E, Mery-Mignard D, et al. Predicitive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials. Ann Oncol 2004;15:1013-1017.
2. Kondo E, Koda K, Takiguchi N, Oda K, Seike K, Ishizuka M, et al. Preoperative natural killer cell activity as a prognostic factor for distant metastasis following surgery for colon cancer. Dig Surg 2003;20:445-451.
3. Heys SD, Walker LG, Deehan DJ, Eremin OE. Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 1998;43:163-168.
4. McMillan DC, Wotherspoon HA, Fearon KC, Sturgeon C, Cooke TG, McArdle CS. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 1995;170;319-322.
5. ten Kate M, Hofland LJ, van Grevenstein WMU, van Koetsveld PV, Jeekel J, van Eijck CH. Influence of proinflammatory cytokines on the adhesion of human colon carcinoma cells to lung microvascular endothelim. Int J Cancer 2004;112:943-950.
6. Higashiyama A, Watanabe H, Okuyama K, Yagita H. Involvement of tumor necrosis factor alpha and very late activation antigen 4/vascular cell adhesion molecule-1 interaction in surgical-stress-enhanced experimental metastasis. Cancer Immunol Immunother 1996;42:231-236.
7. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: Immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 2003;17:S27-S36.
8. Ben-Eliyahu S, Shakhar G, Rosenne E, Levinson Y, Beilin B. Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis: a role for adrenergic mechanisms. Anesthesiology 1999;91:732-740.
9. Riche F, Dosquet C, Panis Y, Valleur P, Laisné MJ, Briard C, et al. Levels of portal and systemic blood cytokines after colectomy in patients with carcinoma or Crohn's disease. J Am Coll Surg 1995;180(6):718-724.
10. Syk I, Hedges SR, Zederfeldt B, Risberg B. Enhanced cytokine response to surgical trauma in patients with colorectal cancer. Int J Surg Invest 1999;1(3):167-176.
11. Ito H, Miki C. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients. Scand J Gastroenterol 1999;34:1139-1143.
12. Syk I, Mangell P, Bjartell A, Jeppsson B. Systemic interleukin-6 response to colorectal surgery originates from the bowel. Dig Surg 2002;19:210-215.
13. Kinoshita T, Ito H, Miki C. Serum interleukin-6 level reflects tumor proliferative activity in colorectal cancer patients. Cancer 1999;85(12):2526-2531.
14. Miki C, Tonouchi H, Wakuda R, Hatada T, Inoue Y, Minato E, et al. Intra-tumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma. Cancer 2002;94(5):1584-1592.
15. Miki C, Konishi N, Ojima E, Hatada T, Inoue Y, Kusunoki M. C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci 2004;49:970-976.
16. McArdle CS, McMillan DC, Hole DJ. The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer. Br J Surg 2006;93:483-488.
17. Ishijima N, Suzuki H. Blood transfusion and postoperative serum interleukin-6 levels in colorectal cancer patients. Hepatogastroenterology 1998;45:1011-1013.
18. Hensler T, Heinemann B, Sauerland S, Lefering R, Bouillon B, Andermahr J, et al. Immunologic alterations associated with high blood transfusion volume after multiple injury: effects on plasmatic cytokine and cytokine receptor concentrations. Shock 2003;20:497-502.
19. Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Br J Surg 2000;87:1553-1562.
20. Jensen LS, Hokland M, Nielsen HJ. A randomized controlled study of the effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1996;83:973-977.
21. Mathiesen O, Lund L, Brodthagen U, Gandrup P, Gunnet N, Balslev I, et al. The effect of previous blood transfuion on lymphocyte subsets and natural killer cell function in patients with colorectal cancer. Vox Sang 1994;67:36-41.
22. Liewald F, Wirsching RP, Zulke C, Demmel N, Mempel W. Influence of blood transfusions on tumor recurrence and survival rate in colorectal carcinoma. Eur J Cancer 1990;26:327-335.
23. Marquet RL, Busch OR, Jeekel J, Heiss MM, Amato AC. Are allogeneic blood transfusions acceptable in elective surgery in colorectal carcinoma? Eur J Cancer 1999;35:352-360.
24. Busch ORC, Hop WCJ, Marquet RL, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer: evidence of a noncausal relationship. Ann Surg 1994;220:791-797.
25. Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859-1867.
26. Edna TH, Bjerkeset T. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 1998;41:451-459.
27. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 1993;80:427-432.
28. Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992;216:633-638.
29. Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastasis. Ann Surg 1991;214:107-113.
30. Beynon J, Davies PW, Billings PJ, Channer JL, Protheroe D, Umpleby HC, et al. Perioperative blood transfusion increases the risk of recurrence in colorectal cancer. Dis Colon Rectum 1989;32:975-979.
31. Blumberg N, Heal J, Chuang C, Murphy P, Agarwal M. Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence. Ann Surg 1988;207:410-415.
32. Parrott NR, Lennard TW, Taylor RM, Proud G, Shenton BK, Johnson ID. Effect of perioperative blood transfusion on recurrence of colorectal cancer. Br J Surg 1986;73:970-973.
33. Wobbes T, Joosen KH, Kuypers HH, Beerthuizen GI, Theeuwes GM. The effect of packed cells and whole blood transfusions on survival after curative resection for colorectal carcinoma. Dis Colon Rectum 1989;32:743-748.
34. Shao W, Edelman L, Sullivan DJ, Nelson EW, Shelby J. Long-term cytokine alterations following allogeneic blood transfusion. J Invest Med 1998;46:161-167.
35. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006;25:CD005033.
36. Busch OR, Hop WC, Hoynck van Papendrect MAW, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372-1376.
37. Cheslyn-Curtis S, Fielding LP, Hittinger R, Hittinger R, Fry JS, Phillips RK. Large bowel cancer: the effect of perioperative blood transfusion on outcome. Ann R Coll Surg Engl 1990;72:53-59.
38. Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M. Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival following potentially curative resection of colorectal cancer. Clin Oncol 2006;18:60-66.
39. Nozoe T, Matsumata T, Sugimachi K. Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 2000;23:263-266.
40. Ikuta S, Miki C, Tanaka K, Konishi N, Mohri Y, Tonouchi H, et al. Serum immunosuppressive acidic protein as an interleukin-6 related index of deteriorating condition in gastric cancer patients. Dig Surg 2003;20:532-538.
41. Hatada T, Miki C. Nutritional status and postoperative cytokine response in colorectal cancer patients. Cytokine 2000;12:1331-1336.
42. Yamashita J, Kurusu Y, Fujino N, Saisyoji T, Ogawa M. Detection of circulating cancer cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg 2000;119:899-905.
43. Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-516.
44. Cristaldi M, Rovatti M, Elli M, Gerlinzani S, Lesma A, Balzarotti L, et al. Lymphocyte subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients. Surg Laparosc Endosc 1997;7:255-261.
45. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 2003;17:S27-S36.
46. McArdle CS, McMillan DC, Hole DJ. Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg 2005;92:1150-1154.
47. Nowacki MP, Szymendera JJ. The strongest prognostic factors in colorectal carcinoma. Surgicopathologic stage of disease and postoperative fever. Dis Colon Rectum 1983;26:263-268.
48. Nespoli A, Gianotti L, Bovo G, Bovo G, Nespoli L, Chiodini P, et al. Correlation between postoperative infections and long-term survival after colorectal resection for cancer. Tumori 2004;90:485-490.
49. Laurent C, Sa Cunha A, Couderc E, Rullier E, Saric J. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 2003;90:1131-1136.
50. Fermor B, Umpleby HC, Lever JV, Symes MO, Williamson RC. Proliferative and metastatic potential of exfoliated colorectal cancer cells. J Natl Cancer Inst 1986;76:347-349.
51. van den Tol PM, van Rossen EE, van Eijck CH, Bonthuis F, Marquet RL, Jeekel H. Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells. Ann Surg 1998;227:242-248.
52. Akyol AM, McGregor JR, Galloway DJ, Murray GD, George WD. Anastomotic leaks in colorectal cancer surgery: a risk factor for recurrence? Int J Colorectal Dis 1991;6:179-183.
53. Akyol AM, McGregor JR, Galloway DJ, Murray G, George WD. Recurrence of colorectal cancer after sutured and stapled large bowel anastomoses. Br J Surg 1991;78:1297-1300.
54. Chang SC, Lin JK, Yang JK, Jiang JK, Chen WC, Lin TC. Longterm outcome of anastomosis leakage after curative resection for mid and low rectal cancer. Hepatogastroenterology 2003;50:1898-1902.
55. Peterson S, Freitag M, Hellmich G, Ludwig K. Anastomotic leakage: impact on local recurrence and survival in surgery of colorectal cancer. Int J Colorectal Dis 1998;13:160-163.
56. Branagan G, Finnis D. Prognosis after anastomotic leakage in colorectal surgery. Dis Colon Rectum 2005;48:1021-106.
57. Walker KG, Bell SW, Rickard MJFX, Mehanna D, Dent OF, Chapuis PH, et al. Anastomotic leakage is predictive of diminished survival after potentially curative resection of colorectal cancer. Ann Surg 2004;240:255-259.
58. Bell SW, Walker KG, Rickard MJFX, Sinclair G, Dent OF, Chapuis PH, et al. Anastomotic leakage after curative anterior resection results in a higher prevalence of local recurrence. Br J Surg 2003;90:1261-1266.
59. Kressner U, Graf W, Mahteme H, Påhlman L, Glimelius B. Septic complications and prognosis after surgery for rectal cancers. Dis Colon Rectum 2002;45:316-321.
60. Sietses C, Beelen RHJ, Meijer S, Cuesta MA. Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications. Langenbeck's Arch Surg 1999;384:250-258.
61. Eriksen MT, Wibe A, Norstein J, Haffner J, Wiig JN. Anastomotic leakage following routine mesorectal excision for rectal cancer in a national cohort of patients. Colorectal Dis 2005;7:51-57.
62. Ito R, Yasui W, Kuniyasu H, Yokozaki H, Tahara E. Expression of interleukin-6 and its effect on the cell growth of gastric carcinoma cell lines. Jpn J Cancer Res 1997;88:953-958.
63. Vittimberga FJ, Foley DP, Meyers WC, Callery MP. Laparoscopic surgery and the systemic immune response. Ann Surg 1998;227:326-334.
64. Allendorf JD, Bessler M, Horvath KD, Marvin MR, Laird DA, Whelan RL. Increased tumor establishment and growth after open vs laparoscopic surgery in mice may be related to differences in postoperative T-cell function. Surg Endosc 1999;13:233-235.
65. Da Costa M, Redmond P, Bouchier-Hyaes DJ. The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases. Surgery 1998;124:516-525.
66. Brivio F, Lissoni P, Perego MS, Lissoni A, Fumagalli L. Abrogation of surgery-induced IL-6 hypersecretion by presurgical immunotherapy with IL-2 and its importance in the prevention of postoperative complications. J Biol Regul Homeost Agents 2001;15:370-374.
67. Yamashita Y, Shimada M, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, et al. Effects of preoperative steroid administration on surgical stress in hepatic resection: prospective randomized trial. Arch Surg 2001;136:328-333.
68. Kilger E, Weis F, Briegel J, Frey L, Goetz AE, Reuter D, et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003;31:1068-1074.
69. Nakamura E, Kitagawa Y, Ozawa S, Suda K, Ando N, Ueda M, et al. Role of steroid administration to reduce inflammation after thoracotomy in a rat surgical stress model. J Surg Res 2006;135:364-369.
70. Aldrighetti L, Pulitano C, Arru M, Finazzi R, Catena M, Soldini L, et al. Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: a prospective randomized study. Liver Transpl 2006;12:941-949.
71. Swails WS, Kenler AS, Driscoll DF, DeMichele SJ, Babineau TJ, Utsunamiya T, et al. Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery. J Parenteral Enteral Nutr 1997;21:266-274.